Erik Meyer

472 total citations
9 papers, 393 citations indexed

About

Erik Meyer is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Erik Meyer has authored 9 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hepatology and 3 papers in Oncology. Recurrent topics in Erik Meyer's work include Liver physiology and pathology (4 papers), TGF-β signaling in diseases (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Erik Meyer is often cited by papers focused on Liver physiology and pathology (4 papers), TGF-β signaling in diseases (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Erik Meyer collaborates with scholars based in Germany, Switzerland and Mexico. Erik Meyer's co-authors include Peter R. Galle, Stephan Kanzler, Ansgar W. Lohse, Peter Schirmacher, F Thieringer, Borut Klopcic, Johannes Herkel, Stefan Biesterfeld, Manfred Blessing and T Maass and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Erik Meyer

9 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Meyer Germany	8	183	162	147	80	50	9	393
K. Mangasser-Stephan Germany	6	203 1.1×	196 1.2×	133 0.9×	85 1.1×	28 0.6×	6	436
Anna Feren United States	7	117 0.6×	154 1.0×	78 0.5×	92 1.1×	38 0.8×	8	345
Mohamed Abou‐Shady Egypt	8	179 1.0×	206 1.3×	126 0.9×	98 1.2×	22 0.4×	14	399
Marzena Swiderska‐Syn United States	10	159 0.9×	146 0.9×	160 1.1×	52 0.7×	34 0.7×	15	387
Kuniharu Akita Japan	4	120 0.7×	193 1.2×	90 0.6×	43 0.5×	47 0.9×	5	338
Azza Karrar United States	9	116 0.6×	81 0.5×	101 0.7×	32 0.4×	67 1.3×	15	315
Takuo Tokairin Japan	13	204 1.1×	203 1.3×	86 0.6×	67 0.8×	34 0.7×	28	513
Xuzhen Yan China	10	121 0.7×	129 0.8×	125 0.9×	53 0.7×	51 1.0×	18	337
Motoyuki Yamagata Japan	9	147 0.8×	101 0.6×	71 0.5×	79 1.0×	15 0.3×	24	351
Kylie P. Matchett United Kingdom	8	155 0.8×	177 1.1×	162 1.1×	68 0.8×	100 2.0×	9	432

Countries citing papers authored by Erik Meyer

Since Specialization

Citations

This map shows the geographic impact of Erik Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Meyer more than expected).

Fields of papers citing papers by Erik Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Meyer. The network helps show where Erik Meyer may publish in the future.

Co-authorship network of co-authors of Erik Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Meyer. A scholar is included among the top collaborators of Erik Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Meyer. Erik Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Thieringer, F, T Maass, Erik Meyer, et al.. (2011). Liver‐specific overexpression of matrix metalloproteinase 9 (MMP‐9) in transgenic mice accelerates development of hepatocellular carcinoma. Molecular Carcinogenesis. 51(6). 439–448. 23 indexed citations

2.

Klopcic, Borut, T Maass, Erik Meyer, et al.. (2007). TGF-β superfamily signaling is essential for tooth and hair morphogenesis and differentiation. European Journal of Cell Biology. 86(11-12). 781–799. 41 indexed citations

3.

Klopcic, Borut, Erik Meyer, Johannes Herkel, et al.. (2006). Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. Journal of Hepatology. 45(3). 419–428. 207 indexed citations

4.

Jin, Hongjun, et al.. (2005). Investigation of CC and CXC chemokine quaternary state mutants. Biochemical and Biophysical Research Communications. 338(2). 987–999. 23 indexed citations

5.

Thieringer, F, Stefan Lüth, Erik Meyer, et al.. (2005). Hepatic over-expression of TGF-beta1 promotes LPS-induced inflammatory cytokine secretion by liver cells and endotoxemic shock. Immunology Letters. 101(2). 217–222. 23 indexed citations

6.

Thieringer, F, Ulrich Schmitt, Erik Meyer, et al.. (2004). 610 Anti IL-6 therapy rescues transgenic mice with liver specific overexpression of TGF-β1 from death after LPS mediated liver injury. Journal of Hepatology. 40. 179–179. 11 indexed citations

7.

Kanzler, Stephan, Erik Meyer, Ansgar W. Lohse, et al.. (2001). Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis. Oncogene. 20(36). 5015–5024. 55 indexed citations

8.

Mest, H.‐J., A Riedel, & Erik Meyer. (1988). PAF-antagonists and thromboxane (TX) antagonists abolish PAF-induced cardiac rhythym disturbances. Prostaglandins. 35(5). 807–807. 1 indexed citations

9.

Laven, H., et al.. (1971). Inherited semisterility for control of harmful insects. II. Degree of sterility and types of translocations in the mosquitoCulex pipiens L.. Cellular and Molecular Life Sciences. 27(8). 968–969. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact